Sponsor Pipeline

Abivax S.A. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
5
Active Trials
3
Recruiting
1
Phase 3
2
Disease Areas
Active Trials by Phase
Phase 3
1
Phase 2
2
Phase 1/2
1
Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT05535946 ABTECT - Maintenance Ulcerative Colitis Active, Not Recruiting
Phase 2
NCT06456593 Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's… Moderately to Severely Active Crohn Disease Recruiting
NCT05177835 Long-term Safety and Efficacy Profile of ABX464 in Subjects With Moderate to Severe… Ulcerative Colitis Active, Not Recruiting
Phase 1/2
NCT03897543 ABX196 in Combination With Nivolumab in Patients With Hepatocellular Carcinoma Carcinoma, Hepatocellular Recruiting
Phase 1
NCT07453784 Study to Evaluate Pharmacokinetics, Relative Bioavailability, Palatability of Obefazimod… Healthy Recruiting
Disease Areas
Ulcerative Colitis (2) Crohn's Disease (1)
Get alerts when Abivax S.A.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free